These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2308979

  • 21. Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
    Shimazaki C, Inaba T, Murakami S, Fujita N, Nakagawa M, Gulati SC, Fried J, Clarkson BD, Wisniewolski R, Wang CY.
    Prog Clin Biol Res; 1990; 333():311-9. PubMed ID: 2308988
    [No Abstract] [Full Text] [Related]

  • 22. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells.
    Tong AW, Lee JC, Stone MJ.
    Blood; 1987 Jan; 69(1):238-45. PubMed ID: 3098320
    [Abstract] [Full Text] [Related]

  • 23. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
    Bellamy WT, Dalton WS, Kailey JM, Gleason MC, McCloskey TM, Dorr RT, Alberts DS.
    Cancer Res; 1988 Nov 15; 48(22):6365-70. PubMed ID: 3180056
    [Abstract] [Full Text] [Related]

  • 24. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A, Papadimitriou C, Serve H, Hoppe B, Koenigsmann M, Reufi B, Oberberg D, Thiel E, Berdel WE.
    Bone Marrow Transplant; 1997 Jun 15; 19(12):1239-46. PubMed ID: 9208119
    [Abstract] [Full Text] [Related]

  • 25. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
    Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S.
    Cancer Res; 1987 Feb 01; 47(3):846-51. PubMed ID: 3492268
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis.
    Frame JN, Sheehy D, Cartagena T, Cirrincione C, O'Reilly RJ, Dupont B, Kernan NA.
    Bone Marrow Transplant; 1989 Jan 01; 4(1):55-61. PubMed ID: 2784335
    [Abstract] [Full Text] [Related]

  • 29. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
    Porter CW, Ganis B, Rustum Y, Wrzosek C, Kramer DL, Bergeron RJ.
    Cancer Res; 1994 Nov 15; 54(22):5917-24. PubMed ID: 7954423
    [Abstract] [Full Text] [Related]

  • 34. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.
    Dalton WS, Durie BG, Alberts DS, Gerlach JH, Cress AE.
    Cancer Res; 1986 Oct 15; 46(10):5125-30. PubMed ID: 2875788
    [Abstract] [Full Text] [Related]

  • 35. Addition of a bone marrow "facilitating cell" population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma.
    Yaroslavskiy B, Colson Y, Ildstad S, Parrish D, Boggs SS.
    Exp Hematol; 1998 Jul 15; 26(7):604-11. PubMed ID: 9657135
    [Abstract] [Full Text] [Related]

  • 36. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
    Stewart AK, Prince HM, Cappe D, Chu P, Lutzko C, Sutherland DR, Dubé ID.
    Cancer Gene Ther; 1997 Jul 15; 4(3):148-56. PubMed ID: 9171933
    [Abstract] [Full Text] [Related]

  • 37. Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells.
    Ayuk FA, Fang L, Fehse B, Zander AR, Kröger N.
    Exp Hematol; 2005 Dec 15; 33(12):1531-6. PubMed ID: 16338496
    [Abstract] [Full Text] [Related]

  • 38. A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy.
    Aihara M, Aihara Y, Schmidt-Wolf G, Schmidt-Wolf I, Sikic BI, Blume KG, Chao NJ.
    Blood; 1991 May 01; 77(9):2079-84. PubMed ID: 1673356
    [Abstract] [Full Text] [Related]

  • 39. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
    Shimazaki C, Wisniewski D, Scheinberg DA, Atzpodien J, Strife A, Gulati S, Fried J, Wisniewolski R, Wang CY, Clarkson BD.
    Blood; 1988 Oct 01; 72(4):1248-54. PubMed ID: 3167207
    [Abstract] [Full Text] [Related]

  • 40. The nature of cells generating human myeloma colonies in vitro.
    Hamburger AW, Kim MB, Salmon SE.
    J Cell Physiol; 1979 Feb 01; 98(2):371-6. PubMed ID: 422663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.